AFELTRA, Antonella Maria Vittoria
 Distribuzione geografica
Continente #
AS - Asia 5.302
NA - Nord America 847
EU - Europa 510
SA - Sud America 26
AF - Africa 8
OC - Oceania 8
Totale 6.701
Nazione #
SG - Singapore 4.608
US - Stati Uniti d'America 804
CN - Cina 404
HK - Hong Kong 220
GB - Regno Unito 140
IT - Italia 134
DE - Germania 73
FI - Finlandia 46
NL - Olanda 38
CA - Canada 28
BR - Brasile 22
TR - Turchia 21
IN - India 19
FR - Francia 14
PL - Polonia 13
MX - Messico 12
CZ - Repubblica Ceca 10
JP - Giappone 10
LT - Lituania 9
AU - Australia 8
ES - Italia 7
AT - Austria 6
UA - Ucraina 6
VN - Vietnam 6
ZA - Sudafrica 4
BD - Bangladesh 3
ID - Indonesia 3
SE - Svezia 3
HU - Ungheria 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
RW - Ruanda 1
SA - Arabia Saudita 1
TL - Timor Orientale 1
TN - Tunisia 1
VG - Isole Vergini Britanniche 1
YT - Mayotte 1
Totale 6.701
Città #
Singapore 217
Hong Kong 216
Hefei 206
Ashburn 184
London 122
Boardman 115
Shanghai 71
Beijing 63
Council Bluffs 59
Munich 56
West Jordan 40
Los Angeles 35
Rome 35
Dallas 33
Amsterdam 30
Turku 24
San Francisco 23
Washington 23
Helsinki 22
Santa Clara 20
Sona 20
Seattle 19
Bari 15
Ankara 14
Toronto 13
Warsaw 13
Pune 11
São Paulo 11
Brno 10
Tokyo 10
Brooklyn 9
Boston 8
Mexico City 8
New York 8
Atlanta 7
Changsha 7
Charlotte 7
Chicago 5
Milan 5
Montreal 5
Chengdu 4
Chennai 4
Duino-Aurisina 4
Haikou 4
Naples 4
Noicattaro 4
Paris 4
State College 4
Ho Chi Minh City 3
Johannesburg 3
Philadelphia 3
Redmond 3
San Jose 3
Secaucus 3
Sydney 3
The Dalles 3
Vienna 3
Vilnius 3
Brest 2
Canberra 2
Central 2
Charleston 2
Cuernavaca 2
Denver 2
Guiyang 2
Handan 2
Herne Bay 2
Honolulu 2
Linyi 2
Manchester 2
Melbourne 2
Messina 2
Perugia 2
Phoenix 2
Reus 2
Rockville 2
Stockholm 2
Tianjin 2
Topeka 2
Ajman 1
Almere Stad 1
Amman 1
Annapolis 1
Atibaia 1
Augusta 1
Bekasi 1
Belgrade 1
Benito Juarez 1
Bologna 1
Borås 1
Bourne 1
Brasília 1
Budapest 1
Buffalo 1
Caldas Novas 1
Calgary 1
Carney 1
Ciudad del Este 1
Clarksburg 1
Cleveland 1
Totale 1.924
Nome #
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 198
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 198
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 197
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 196
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 195
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 194
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 191
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 189
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 183
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 182
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 176
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 176
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 174
Leptin in immuno-rheumatological diseases 169
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 105
GH-resistance in different stages of chronic liver disease 102
Diabetes in chronic liver disease: from old concepts to new evidence 100
Enhanced portal flow velocity and volume following Iloprost treatment 98
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 97
Automatic acquisition of Immunofluorescence images: algorithms and evaluation 97
Radiofrequency ablation of hepatic tissue: a new experimental animal model 94
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 93
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 91
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 88
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 88
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 87
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 85
Cannabinoids in Autoimmune and Rheumatic Diseases 84
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 84
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 84
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 83
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 82
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 82
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 81
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 80
Leptin in autoimmune mechanisms of systemic rheumatic diseases 80
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 79
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 78
ANA testing in ‘real life’ 78
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 74
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 72
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 68
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 66
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 64
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 62
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 60
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 59
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 50
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 48
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 44
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 39
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 36
TNF-alpha and growth hormone resistance in patients with chronic liver disease 35
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 34
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 31
Pain and Frailty in Hospitalized Older Adults 31
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 31
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 30
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 29
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 29
Low level tumor necrosis factor-alpha protects cardiomyocytes against high level tumor necrosis factor-alpha: brief insight into a beneficial paradox 29
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 29
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 28
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 27
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 27
The classification of Crithidia luciliae immunofluorescence test (CLIFT) using a novel automated system 25
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 25
Matters of the heart: The case of TNF-alpha targeting drugs 25
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 25
Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints 24
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 24
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 24
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 24
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 23
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 23
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 23
Surgical complications after resection of adrenal carcinoma 23
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 23
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 23
Utility of ultrasound in the diagnosis of chronic worsened gout 22
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 22
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 22
Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk 22
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis 22
Tumour necrosis factor alpha (TNFα)cardiomyocyte preconditioning: clues to explain anti-TNFα agents contraindication in severe heart failure 21
Strain Ultrasound Elastography in the Achilles Tendon of Ankylosing Spondylitis Patients Treated With Anti-TNF-α: A Preliminary Study. 21
Indirect immunofluorescence in autoimmune diseases: assessment of digital images for diagnostic purpose 21
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 21
Erectile dysfunction: Imbalance between pro-angiogenic and anti-angiogenic factors in systemic sclerosis 20
Serum level of endostatin and digital ulcers in systemic sclerosis patients 20
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 20
Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis 19
Intrarenal arterial stiffness is increased in systemic sclerosis patients with anti-ribonucleic acid polymerase III antibodies 19
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 19
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 19
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 19
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 19
Tnf-alpha induced cardioprotection: effects on reactive oxygen species (ros) and apoptosis 19
Phase angle could be a marker of microvascular damage in systemic sclerosis 18
In systemic sclerosis, microvascular and hands digital arteries damage correlates with serum levels of endostatin 17
Totale 6.706
Categoria #
all - tutte 40.936
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.936


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022133 0 1 0 0 1 2 2 6 14 4 2 101
2022/2023137 19 0 0 2 38 2 8 7 2 3 55 1
2023/2024439 26 39 20 37 34 167 5 25 5 48 12 21
2024/20255.517 58 41 143 42 94 123 40 25 265 355 1.874 2.457
2025/2026541 324 193 24 0 0 0 0 0 0 0 0 0
Totale 6.767